Buscador de fondos de inversión: Resultado de la búsqueda: Resumen

Ir a la navegación. Ir al contenido.
Acceso a quefondos Servicios Institucionales Suscríbete a quefondos
Logo quefondos.com
  • Fondos de Inversión submenu_fondos
    • Buscador
    • Comparador
    • Ranking
    • Análisis
    • Noticias
    • Rincón del inversor
    • Recursos
  • Planes de Pensiones submenu_planes
    • Buscador
    • Comparador
    • Ranking
    • Análisis
    • Noticias
    • Rincón del inversor
    • Recursos
  • Fondos de Inversión
    • Buscador Buscador
      • Buscador sencillo
      • Buscador avanzado
      • Categorías VDOS
    • Comparador Comparador
    • Ranking Ranking
    • Análisis Análisis
    • Noticias Noticias
    • Rincón del inversor Rincón del inversor
    • Recursos Recursos
  1. Fondos de Inversión
  2. Buscador

Resultado de la búsqueda

  • Resumen
  • Valor liquidativo
  • % a corto plazo
  • % a largo plazo
  • Riesgo
  • Comisiones
Resultado de la búsqueda: Resumen
Fondo
Ordenar ascendenteOrdenar descendente
Categoría VDOS
Ordenar ascendenteOrdenar descendente
Valor liquidativo
Ordenar ascendenteOrdenar descendente
Fecha
Ordenar ascendenteOrdenar descendente
Rentabilidades (%)Rating VDOS
Ordenar ascendenteOrdenar descendente
2026
Ordenar ascendenteOrdenar descendente
3 años
Ordenar ascendenteOrdenar descendente
Resultados por página: 10 | 20 | 50 | 100Se muestran de 40601 a 40700 de un total de 43668 fondos
UBS (LUX) CREDIT INCOME P-ACCRFI GLOBAL116,65944416/09/20261,72%8,88%***Rating VDOS: 3 estrellas
UBS (LUX) CREDIT INCOME P-QDISTRFI GLOBAL91,07220216/09/2026-1,20%-1,94%**Rating VDOS: 2 estrellas
UBS (LUX) CREDIT INCOME Q-ACCRFI GLOBAL118,74837516/09/20261,86%9,53%***Rating VDOS: 3 estrellas
UBS (LUX) CREDIT INCOME Q-QDISTRFI GLOBAL91,16754816/09/2026-1,22%-1,93%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) I-A1-ACCRVI SALUD1.238,60726016/09/2026-0,19%5,66%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) P-ACCRVI SALUD117,91724016/09/2026-0,84%3,00%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) Q-ACCRVI SALUD125,31484816/09/2026-0,22%5,51%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) QL-ACCRVI SALUD61,26574216/09/2026-0,10%·NDRating VDOS: ND
UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) I-A1-ACCRVI SALUD1.212,67000016/09/20262,70%11,50%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) K-1-ACCRVI SALUD1.558,41000016/09/20262,56%11,07%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) P-ACCRVI SALUD355,46000016/09/20262,04%8,73%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) Q-ACCRVI SALUD123,45000016/09/20262,67%11,36%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) QL-ACCRVI SALUD62,96000016/09/20262,79%·NDRating VDOS: ND
UBS (LUX) DIGITAL HEALTH EQUITY (EUR) P-DISTRVI SALUD119,38000016/09/20265,39%8,24%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (EUR) Q-ACCRVI SALUD87,46000016/09/20266,05%10,88%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) Q-ACCRVI SALUD117,98460516/09/20265,92%17,43%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) QL-ACCRVI SALUD70,22393316/09/20266,05%·NDRating VDOS: ND
UBS (LUX) DIGITAL HEALTH EQUITY I-A1-ACCRVI SALUD1.865,77099816/09/20266,13%10,92%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY I-A2-ACCRVI SALUD563,17933616/09/20266,16%11,26%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY I-B-ACCRVI SALUD1.549,38025516/09/20266,72%13,91%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACCRVI SALUD700,53740116/09/20265,98%10,47%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY N-ACCRVI SALUD140,47846116/09/20264,47%5,45%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY P-ACCRVI SALUD594,07124916/09/20265,45%8,17%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY Q-ACCRVI SALUD138,64089516/09/20266,11%10,79%**Rating VDOS: 2 estrellas
UBS (LUX) DIGITAL HEALTH EQUITY QL-ACCRVI SALUD63,18800416/09/20266,23%·NDRating VDOS: ND
UBS (LUX) DIGITAL HEALTH EQUITY SEEDING P-ACCRVI SALUD1.479,62208516/09/20266,35%12,14%**Rating VDOS: 2 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) P-ACCDEUDA PÚBLICA EMERGENTES100,30636017/09/2026-2,68%24,85%****Rating VDOS: 4 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) P-DISTDEUDA PÚBLICA EMERGENTES54,83836917/09/2026-2,67%8,79%**Rating VDOS: 2 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) Q-DISTDEUDA PÚBLICA EMERGENTES73,32558617/09/2026-2,17%8,78%**Rating VDOS: 2 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) QL-DISTDEUDA PÚBLICA EMERGENTES114,66300417/09/2026-1,96%·NDRating VDOS: ND
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) P-ACCDEUDA PÚBLICA EMERGENTES107,46000017/09/20260,53%32,65%****Rating VDOS: 4 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) QL-ACCDEUDA PÚBLICA EMERGENTES116,05000017/09/20261,28%·NDRating VDOS: ND
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) F-ACCDEUDA PÚBLICA EMERGENTES2.271,64881117/09/20264,98%34,57%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-A1-ACCDEUDA PÚBLICA EMERGENTES197,44795717/09/20264,83%33,77%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-B-ACCDEUDA PÚBLICA EMERGENTES220,42505017/09/20265,26%36,14%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-X-ACCDEUDA PÚBLICA EMERGENTES223,42130517/09/20265,35%36,61%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) P-ACCDEUDA PÚBLICA EMERGENTES1.951,37183217/09/20264,18%30,31%****Rating VDOS: 4 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) P-MDISTDEUDA PÚBLICA EMERGENTES42,13047617/09/2026-2,61%4,62%**Rating VDOS: 2 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) Q-ACCDEUDA PÚBLICA EMERGENTES125,96463717/09/20264,72%33,20%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) Q-DISTDEUDA PÚBLICA EMERGENTES70,86490717/09/20264,72%13,99%***Rating VDOS: 3 estrellas
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-ACCDEUDA PÚBLICA EMERGENTES105,01698517/09/20264,94%·NDRating VDOS: ND
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-DISTDEUDA PÚBLICA EMERGENTES99,83450917/09/20264,93%·NDRating VDOS: ND
UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) U-X-ACCDEUDA PÚBLICA EMERGENTES15.953,30546117/09/20265,35%36,61%*****Rating VDOS: 5 estrellas
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-A1-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.020,62652116/09/2026-5,31%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-B-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.086,82400316/09/2026-5,00%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) K-1-ACCDEUDA PRIVADA EMERGENTES HRD CCY121,33559116/09/2026-5,41%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) P-ACCDEUDA PRIVADA EMERGENTES HRD CCY113,15483116/09/2026-5,76%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-A1-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.134,04000016/09/2026-2,36%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-B-DISTDEUDA PRIVADA EMERGENTES HRD CCY1.056,37000016/09/2026-2,02%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) K-1-ACCDEUDA PRIVADA EMERGENTES HRD CCY131,23000016/09/2026-2,45%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) P-ACCDEUDA PRIVADA EMERGENTES HRD CCY122,16000016/09/2026-2,82%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) Q-ACCDEUDA PRIVADA EMERGENTES HRD CCY104,51000016/09/2026-2,55%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.260,19762516/09/20260,65%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.069,00407416/09/20260,72%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACCDEUDA PRIVADA EMERGENTES HRD CCY1.260,37964816/09/20261,00%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DISTDEUDA PRIVADA EMERGENTES HRD CCY779,89078616/09/20261,00%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACCDEUDA PRIVADA EMERGENTES HRD CCY144,12758916/09/20260,55%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DISTDEUDA PRIVADA EMERGENTES HRD CCY809,40452516/09/20260,55%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACCDEUDA PRIVADA EMERGENTES HRD CCY134,38502216/09/20260,19%·NDRating VDOS: ND
UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACCDEUDA PRIVADA EMERGENTES HRD CCY114,76120316/09/20260,48%·NDRating VDOS: ND
UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACCRVI BIOTECNOLOGÍA944,84801017/09/202625,11%51,32%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACCRVI BIOTECNOLOGÍA428,69959117/09/202626,02%56,03%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACCRVI BIOTECNOLOGÍA140,03135617/09/202626,20%56,98%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACCRVI CHINA76,60000017/09/2026-14,15%3,58%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACCRVI CHINA62,66000017/09/2026-13,45%6,93%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACCRVI CHINA83,00000017/09/2026-10,19%5,85%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACCRVI CHINA72,60000017/09/2026-10,93%2,17%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) Q-ACCRVI CHINA107,08000017/09/2026-10,21%5,47%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) F-ACCRVI CHINA153,54063217/09/2026-10,02%6,34%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A1-ACCRVI CHINA167,93833317/09/2026-10,15%5,70%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A3-ACCRVI CHINA74,21827417/09/2026-10,02%6,35%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) P-ACCRVI CHINA1.067,84252217/09/2026-10,90%2,02%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) Q-ACCRVI CHINA158,87117817/09/2026-10,18%5,31%*Rating VDOS: 1 estrella
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (CHF HEDGED) P-ACCRVI EMERGENTES178,34354517/09/202623,99%68,49%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (CHF HEDGED) Q-ACCRVI EMERGENTES212,08535817/09/202624,82%73,32%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (EUR) N-ACCRVI EMERGENTES294,31000017/09/202632,99%75,12%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) P-ACCRVI EMERGENTES219,17080417/09/202633,36%76,62%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) Q-ACCRVI EMERGENTES240,37975817/09/202634,25%81,67%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (SGD) P-ACCRVI EMERGENTES228,02895817/09/202633,36%76,75%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - EURO COUNTRIES OPPORTUNITY (EUR) P-ACCRV EURO179,44000017/09/202615,11%43,94%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EURO COUNTRIES OPPORTUNITY (EUR) Q-ACCRV EURO272,29000017/09/202615,78%47,54%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) I-A1-ACCRVI EUROPA397,60000017/09/202615,37%39,77%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) P-ACCRVI EUROPA1.480,37000017/09/202614,45%35,14%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) Q-ACCRVI EUROPA389,62000017/09/202615,17%38,62%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) (USD HEDGED) P-ACCRVI EUROPA265,57791117/09/202618,55%32,40%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) (USD HEDGED) Q-ACCRVI EUROPA241,26818217/09/202619,30%35,80%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (CHF PORTFOLIO HEDGED) F-ACCRVI GLOBAL162,64525717/09/20266,45%44,19%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR HEDGED) P-ACCRVI GLOBAL198,35000017/09/20268,07%47,00%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) P-ACCRVI GLOBAL131,03000017/09/202612,12%·NDRating VDOS: ND
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) P-DISTRVI GLOBAL376,27000017/09/202612,11%45,49%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR PORTFOLIO HEDGED) F-ACCRVI GLOBAL166,41000017/09/20269,94%52,81%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) Q-ACCRVI GLOBAL253,79000017/09/202612,77%48,98%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (GBP PORTFOLIO HEDGED) F-ACCRVI GLOBAL203,89141317/09/202613,01%59,62%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) P-ACCRVI GLOBAL1.921,53993617/09/202612,21%45,46%***Rating VDOS: 3 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) Q-ACCRVI GLOBAL287,81465017/09/202612,88%48,95%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (USD PORTFOLIO HEDGED) F-ACCRVI GLOBAL155,30006117/09/202614,03%50,57%****Rating VDOS: 4 estrellas
UBS (LUX) EQUITY FUND - GREATER CHINA (USD) (CHF HEDGED) P-ACCRVI CHINA195,09824617/09/2026-12,31%10,43%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - GREATER CHINA (USD) (CHF HEDGED) Q-ACCRVI CHINA185,50602217/09/2026-11,60%14,28%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - GREATER CHINA (USD) (EUR HEDGED) P-ACCRVI CHINA208,18000017/09/2026-9,32%16,76%**Rating VDOS: 2 estrellas
UBS (LUX) EQUITY FUND - GREATER CHINA (USD) (EUR HEDGED) Q-ACCRVI CHINA194,96000017/09/2026-8,58%20,83%**Rating VDOS: 2 estrellas
//foo
Mapa | Versión móvil | Suscríbete a quefondos | Configurador RSS © 2011 VDOS Stochastics | Información Legal | Contacto
Logo VDOS